Episode 6: UCB's $1.15B US Acquisition, GBL's €500M BUKO Deal & China Blocks Meta-Manus

Welcome to the sixth episode of The Finance Show, Belgium's podcast for corporate finance news, insights, and career guidance.In this episode:Belgian deals:UCB acquires US biotech Neurona Therapeutics for up to $1.15 billion, expanding its leadership in epilepsy with a cell therapy bet.GBL deploys another €500M to acquire a majority stake in Dutch traffic management specialist BUKO, executing its new direct private assets strategy.Global finance:China blocks Meta's $2 billion acquisition of AI startup Manus, sending a powerful message in the US-China tech race.New episodes every two weeks.(00:00) Introduction(01:36) UCB, $1.15B Acquisition of Neurona Therapeutics(08:29) GBL, €500M Majority Stake in BUKO Group(15:29) Meta-Manus, China Blocks $2B AI Deal(22:52) ConclusionGet free access to the Tracker: ⁠Tracker⁠Check out our website: ⁠The Finance Show Website⁠